Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...
A 0.6-second jump might sound small, but for Tesla fans, it’s a total game-changer. From a Christmas gift to a performance ...
Bitopertin was awarded the Commissioner’s National Priority Review Voucher (CNPV) and NDA is currently under FDA reviewUpdated data from the Phase 2 study of DISC-0974 in patients with myelofibrosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback